comparemela.com

Ronaldj Zenk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Humanetics Corporation Awarded Contract From Department of Defense to Develop First FDA Approved Dru

MINNEAPOLIS (BUSINESS WIRE) Humanetics Corporation (Humanetics) announced today that it was awarded a 5-year contract from the Department of Defense (DOD) to develop its drug, BIO 300, as a medical countermeasure to prevent bodily harm caused by acute exposure to radiation. The contract is in the form of an Other.

BIO 300 Featured at the 2023 Military Health System Research Symposium

The presentation provided an overview of recent data from studies with BIO 300 for the prevention of acute radiation syndromeMINNEAPOLIS (BUSINESS WIRE) Updates on the development of Humanetics Corporation’s (Humanetics) new drug candidate, BIO 300, were presented at the 2023 Military Health System Research Sympos.

BIO 300 Demonstrates Protection Against Radiation-Induced Lung Injury

Efficacy of BIO 300 was compared to PEGfilgrastim (Neulasta®).MINNEAPOLIS (BUSINESS WIRE) A recently published paper in Radiation Research, the official journal of the Radiation Research Society, details the results from studies conducted with Humanetics Corporation’s (Humanetics) new radioprotective drug, BIO 300.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.